Junction Growth Investors

Junction Growth Investors is a European growth-stage venture fund with London presence that focuses on the energy transition, with peripheral exposure to deep engineering and infrastructure that intersects with healthcare deep tech. The firm’s primary thesis centers on companies enabling decarbonization, electrification, and sustainable industrial systems, and its healthcare-adjacent activity is opportunistic rather than thematic. As a result, Junction is not a healthcare specialist and is not framed as an AI investor; limited public information is available about specific named investment partners working on health-adjacent deals within the fund.

Junction invests at Series B and Growth stages, with checks in the $5M to $25M range, sized to lead or anchor growth rounds for mid-stage companies. Geographic focus is Europe, with sourcing concentrated in the United Kingdom and Western European markets aligned to the energy transition mandate. The fund typically co-invests with dedicated climate funds and growth-stage generalists rather than healthcare specialists.

For founders, Junction Growth Investors is most relevant to deep tech companies whose technology straddles industrial systems and the climate transition while touching health-adjacent applications such as biological infrastructure, environmental monitoring, or sustainable life sciences hardware. CEOs should expect diligence to engage substantively with sustainability metrics, commercial scalability, and the structural drivers of the energy transition. Founders running pure clinical therapeutics, healthcare software, or consumer wellness companies will not find Junction a natural fit. For European deep tech founders building scaled platforms with credible energy transition relevance, the firm represents a meaningful growth partner.